Robin is the Professor of Neurology, University of California, San Francisco School of Medicine. He moved to Imperial College London in 2008 after obtaining a PhD in psychopharmacology from the University of Bristol. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA, and DMT, and two clinical trials of psilocybin for depression. He has authored over 127 papers. Robin founded the Centre for Psychedelic Research at Imperial College London in 2019, and in 2021, was named in TIME magazine’s "100 Next" – a list of 100 rising stars shaping the future.